Endocrine adjuvant therapy in breast cancer.
D000477:Alkylating Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D004965:Estrogen Antagonists; D005260:Female; D006727:Hormone Antagonists / Q000627:therapeutic use; D006801:Humans; D013629:Tamoxifen / Q000627:therapeutic use
D000477:Alkylating Agents; D004965:Estrogen Antagonists; D006727:Hormone Antagonists; D013629:Tamoxifen